Prescription Drug Information: Abacavir (Page 7 of 7)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label
(click image for full-size original)
carton
(click image for full-size original)
ABACAVIR abacavir tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:69097-514
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ABACAVIR SULFATE (ABACAVIR) ABACAVIR 300 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A CORN
STARCH, CORN
MAGNESIUM STEARATE
SILICON DIOXIDE
TITANIUM DIOXIDE
HYPROMELLOSE 2910 (3 MPA.S)
POLYETHYLENE GLYCOL 400
FERRIC OXIDE YELLOW
POLYSORBATE 80
Product Characteristics
Color YELLOW Score 2 pieces
Shape CAPSULE Size 19mm
Flavor Imprint Code 5;14
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:69097-514-03 60 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078119 11/21/2017
Labeler — Cipla USA Inc. (078719707)
Registrant — Cipla USA Inc. (078719707)
Establishment
Name Address ID/FEI Operations
Cipla Patalganga 916940208 ANALYSIS (69097-514), LABEL (69097-514), MANUFACTURE (69097-514), PACK (69097-514)
Establishment
Name Address ID/FEI Operations
Cipla Kurkumbh 917066446 API MANUFACTURE (69097-514)
Establishment
Name Address ID/FEI Operations
Mylan-Laboratories Limited 650438158 API MANUFACTURE (69097-514)

Revised: 12/2020 Cipla USA Inc.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.